FazaClo Outcomes in the Control of Schizophrenia (FOCUS) Study Survey
Clinical trial NCT00683891 · COMPLETED
Trial details
- NCT number
- NCT00683891
- Sponsor
- Azur Pharma, Inc
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.